In the second installment of this 6-part “Case-Based Exchange” series, Gabriela Almeida, Oncology Nurse Navigator at the University of Chicago Medicine, discusses side effects of checkpoint inhibitors for endometrial cancer treatment. Part 2 underscores the importance of recognizing and managing the side effects of immune checkpoint inhibitors, equipping healthcare professionals with the knowledge to provide safe and effective care for patients with endometrial cancer.
Also, see the Interview with the Innovators Presents: Advanced Endometrial Cancer Educational Series
To sign up for our newsletter or print publications, please enter your contact information below.
